AdaptHealth Q1 revenue falls 1.8% to $777.9 million; 2025 revenue and EBITDA guidance cut
AdaptHealth reported first-quarter 2025 net revenue of $777.9 million, down 1.8% from a year earlier, and a net loss attributable to the company of $7.2 million, compared with a $2.1 million loss in the prior-year quarter. Adjusted EBITDA fell 19.3% to $127.9 million. The company also lowered its fiscal 2025 net revenue and adjusted EBITDA guidance to account for the disposition of certain incontinence assets, reducing its outlook for shareholders.
Key points
- Net revenue was $777.9 million, down from $792.5 million in the first quarter of 2024, a decrease of 1.8%.
- Net loss attributable to AdaptHealth Corp. was $7.2 million, compared with a net loss of $2.1 million a year earlier.
- Fiscal 2025 net revenue guidance was lowered to $3.18 billion to $3.32 billion from $3.22 billion to $3.36 billion; adjusted EBITDA guidance was lowered to $665 million to $705 million from $670 million to $710 million.
- Free cash flow guidance of $180 million to $220 million was unchanged; first-quarter cash flow from operations was $95.5 million.
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.